{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:13:55Z","timestamp":1789010035385,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00428-021-03022-8","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T15:59:48Z","timestamp":1612281588000},"page":"133-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features"],"prefix":"10.1007","volume":"479","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-0320","authenticated-orcid":false,"given":"Sietse M.","family":"Aukema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio A.","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Oehl-Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke G.","family":"Bosga-Bouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mels","family":"Hoogendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Bittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Murga Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kreuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bausinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Belder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-2236","authenticated-orcid":false,"given":"Martin J. S.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"3022_CR1","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1182\/blood-2017-08-737502","volume":"132","author":"M Dreyling","year":"2018","unstructured":"Dreyling M, Klapper W, Rule S (2018) Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge! Blood 132:2722\u20132729. https:\/\/doi.org\/10.1182\/blood-2017-08-737502","journal-title":"Blood"},{"key":"3022_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","volume":"468","author":"B Sander","year":"2016","unstructured":"Sander B, Quintanilla-Martinez L, Ott G, Xerri L, Kuzu I, Chan JKC, Swerdlow SH, Campo E (2016) Mantle cell lymphoma--a spectrum from indolent to aggressive disease. Virchows Arch 468:245\u2013257. https:\/\/doi.org\/10.1007\/s00428-015-1840-6","journal-title":"Virchows Arch"},{"key":"3022_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C L\u00f3pez","year":"2019","unstructured":"L\u00f3pez C, Kleinheinz K, Aukema SM et al (2019) Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun 10:1459. https:\/\/doi.org\/10.1038\/s41467-019-08578-3","journal-title":"Nat Commun"},{"key":"3022_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/10428190701836845","volume":"49","author":"L Christie","year":"2008","unstructured":"Christie L, Kernohan N, Levison D, Sales M, Cunningham J, Gillespie K, Batstone P, Meiklejohn D, Goodlad J (2008) C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: an adverse prognostic indicator? Leuk Lymphoma 49:470\u2013476. https:\/\/doi.org\/10.1080\/10428190701836845","journal-title":"Leuk Lymphoma"},{"key":"3022_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ajcp\/aqz208","volume":"153","author":"JB Ziemba","year":"2020","unstructured":"Ziemba JB, Wolf Z, Weinstock M, Asakrah S (2020) Double-hit and triple-hit follicular lymphoma. Am J Clin Pathol 153:672\u2013685. https:\/\/doi.org\/10.1093\/ajcp\/aqz208","journal-title":"Am J Clin Pathol"},{"key":"3022_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/his.13316","volume":"71","author":"SM Aukema","year":"2017","unstructured":"Aukema SM, van Pel R, Nagel I, Bens S, Siebert R, Rosati S, van den Berg E, Bosga-Bouwer AG, Kibbelaar RE, Hoogendoorn M, van Imhoff GW, Kluin-Nelemans HC, Kluin PM, Nijland M (2017) MYC expression and translocation analyses in low-grade and transformed follicular lymphoma. Histopathology 71:960\u2013971. https:\/\/doi.org\/10.1111\/his.13316","journal-title":"Histopathology"},{"key":"3022_CR7","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","volume":"117","author":"SM Aukema","year":"2011","unstructured":"Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM (2011) Double-hit B-cell lymphomas. Blood 117:2319\u20132331. https:\/\/doi.org\/10.1182\/blood-2010-09-297879","journal-title":"Blood"},{"key":"3022_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood-2016-05-718775","volume":"129","author":"B Dai","year":"2017","unstructured":"Dai B, Grau M, Juilland M, Klener P, H\u00f6ring E, Molinsky J, Schimmack G, Aukema SM, Hoster E, Vogt N, Staiger AM, Erdmann T, Xu W, Erdmann K, Dzyuba N, Madle H, Berdel WE, Trneny M, Dreyling M, J\u00f6hrens K, Lenz P, Rosenwald A, Siebert R, Tzankov A, Klapper W, Anagnostopoulos I, Krappmann D, Ott G, Thome M, Lenz G (2017) B-cell receptor\u2013driven MALT1 activity regulates MYC signaling in mantle cell lymphoma. Blood 129:333\u2013346. https:\/\/doi.org\/10.1182\/blood-2016-05-718775","journal-title":"Blood"},{"key":"3022_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","volume":"41","author":"Z Hu","year":"2017","unstructured":"Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN, Lu X, Pham LV, Young KH, Wang W, Hu S (2017) Mantle cell lymphoma with MYC rearrangement: a report of 17 patients. Am J Surg Pathol 41:216\u2013224. https:\/\/doi.org\/10.1097\/PAS.0000000000000758","journal-title":"Am J Surg Pathol"},{"key":"3022_CR10","doi-asserted-by":"publisher","unstructured":"Wang L, Tang G, Medeiros LJ, Xu J, Huang W, Yin CC, Wang M, Jain P, Lin P, Li S (2020) MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica.:haematol.2019.243071. https:\/\/doi.org\/10.3324\/haematol.2019.243071","DOI":"10.3324\/haematol.2019.243071"},{"key":"3022_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12308-014-0229-9","volume":"8","author":"ME Kallen","year":"2015","unstructured":"Kallen ME, Rao NP, Kulkarni SK, Pullarkat ST, Said J, Tirado CA, Ahmed RS, Miller JM, Chung PY, Kahn DG, Song SX (2015) B-lymphoblastic transformation of mantle cell lymphoma\/leukemia with \u201cdouble hit\u201d changes. J Hematop 8:31\u201336. https:\/\/doi.org\/10.1007\/s12308-014-0229-9","journal-title":"J Hematop"},{"key":"3022_CR12","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2018-03-842088","volume":"132","author":"R Wagener","year":"2018","unstructured":"Wagener R, L\u00f3pez C, Kleinheinz K, Bausinger J, Aukema SM, Nagel I, Toprak UH, Seufert J, Altm\u00fcller J, Thiele H, Schneider C, Kolarova J, Park J, H\u00fcbschmann D, Murga Penas EM, Drexler HG, Attarbaschi A, Hovland R, Kjeldsen E, Kneba M, Kontny U, de Leval L, N\u00fcrnberg P, Oschlies I, Oscier D, Schlegelberger B, Stilgenbauer S, W\u00f6ssmann W, Schlesner M, Burkhardt B, Klapper W, Jaffe ES, K\u00fcppers R, Siebert R (2018) IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. Blood 132:2280\u20132285. https:\/\/doi.org\/10.1182\/blood-2018-03-842088","journal-title":"Blood"},{"key":"3022_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/modpathol.2012.142","volume":"26","author":"KP Patel","year":"2013","unstructured":"Patel KP, Khokhar FA, Muzzafar T, James You M, Bueso-Ramos CE, Ravandi F, Pierce S, Medeiros LJ (2013) TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation. Mod Pathol 26:195\u2013203. https:\/\/doi.org\/10.1038\/modpathol.2012.142","journal-title":"Mod Pathol"},{"key":"3022_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41379-018-0112-9","volume":"32","author":"CY Ok","year":"2019","unstructured":"Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S (2019) High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol 32:48\u201358. https:\/\/doi.org\/10.1038\/s41379-018-0112-9","journal-title":"Mod Pathol"},{"key":"3022_CR15","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TFE, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, K\u00fchn M, Lenze D, Lichter P, Martin-Subero JI, M\u00f6ller P, M\u00fcller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, St\u00fcrzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Tr\u00fcmper L, Stein H, Siebert R (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419\u20132430. https:\/\/doi.org\/10.1056\/NEJMoa055351","journal-title":"N Engl J Med"},{"key":"3022_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3324\/haematol.2013.091827","volume":"99","author":"SM Aukema","year":"2014","unstructured":"Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Kuppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trumper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R, for the Molecular Mechanisms in Malignant Lymphomas (MMML) Network Project (2014) Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica 99:726\u2013735. https:\/\/doi.org\/10.3324\/haematol.2013.091827","journal-title":"Haematologica"},{"key":"3022_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","volume":"2","author":"W Klapper","year":"2009","unstructured":"Klapper W, Hoster E, Determann O et al (2009) Ki-67 as a prognostic marker in mantle cell lymphoma\u2014consensus guidelines of the pathology panel of the European MCL Network. J Hematop 2:103\u2013111. https:\/\/doi.org\/10.1007\/s12308-009-0036-x","journal-title":"J Hematop"},{"key":"3022_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","volume":"131","author":"SM Aukema","year":"2018","unstructured":"Aukema SM, Hoster E, Rosenwald A, Canoni D, Delfau-Larue MH, Rymkiewicz G, Thorns C, Hartmann S, Kluin-Nelemans H, Hermine O, Dreyling M, Klapper W (2018) Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood 131:417\u2013420. https:\/\/doi.org\/10.1182\/blood-2017-07-797019","journal-title":"Blood"},{"key":"3022_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00428-020-02750-7","volume":"477","author":"GA Croci","year":"2020","unstructured":"Croci GA, Hoster E, Bea S et al (2020) Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11. Virchows Arch 477:259\u2013267. https:\/\/doi.org\/10.1007\/s00428-020-02750-7","journal-title":"Virchows Arch"},{"key":"3022_CR20","doi-asserted-by":"crossref","unstructured":"McGowan-Jordan J, Simons A, Schmid M (Eds) (2016) ISCN 2016 An international system for human cytogenomic nomenclature. Karger, Basel.","DOI":"10.1159\/isbn.978-3-318-06861-0"},{"key":"3022_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bjh.13501","volume":"170","author":"SM Aukema","year":"2015","unstructured":"Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenl\u00f6hner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM (2015) Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations. Br J Haematol 170:814\u2013825. https:\/\/doi.org\/10.1111\/bjh.13501","journal-title":"Br J Haematol"},{"key":"3022_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ijc.10169","volume":"98","author":"JI Martin-Subero","year":"2002","unstructured":"Martin-Subero JI, Harder L, Gesk S et al (2002) Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 98:470\u2013474. https:\/\/doi.org\/10.1002\/ijc.10169","journal-title":"Int J Cancer"},{"issue":"1","key":"3022_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1365-2559.2010.03700.x","volume":"58","author":"P Kluin","year":"2011","unstructured":"Kluin P, Schuuring E (2011) Molecular cytogenetics of lymphoma: where do we stand in 2010? Histopathology 58(1):128\u2013144. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03700.x","journal-title":"Histopathology"},{"issue":"8","key":"3022_CR24","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","volume":"111","author":"FE Craig","year":"2008","unstructured":"Craig FE, Foon KA (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111(8):3941\u20133967. https:\/\/doi.org\/10.1182\/blood-2007-11-120535","journal-title":"Blood"},{"key":"3022_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/his.13286","volume":"71","author":"M Pizzi","year":"2017","unstructured":"Pizzi M, Agostinelli C, Righi S, Gazzola A, Mannu C, Galuppini F, Fassan M, Visentin A, Piazza F, Semenzato GC, Rugge M, Sabattini E (2017) Aberrant expression of CD10 and BCL6 in mantle cell lymphoma. Histopathology 71:769\u2013777. https:\/\/doi.org\/10.1111\/his.13286","journal-title":"Histopathology"},{"key":"3022_CR26","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.18632\/oncotarget.23571","volume":"9","author":"J Xu","year":"2018","unstructured":"Xu J, Medeiros LJ, Saksena A et al (2018) CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases. Oncotarget 9:11441\u201311450. https:\/\/doi.org\/10.18632\/oncotarget.23571","journal-title":"Oncotarget"},{"key":"3022_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/his.13161","volume":"70","author":"W-Y Chuang","year":"2017","unstructured":"Chuang W-Y, Chang H, Chang G-J, Wang TH, Chang YS, Wang TH, Yeh CJ, Ueng SH, Chien HP, Chang CY, Wan YL, Hsueh C (2017) Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall. Histopathology 70:986\u2013999. https:\/\/doi.org\/10.1111\/his.13161","journal-title":"Histopathology"},{"key":"3022_CR28","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","volume":"119","author":"L Nygren","year":"2012","unstructured":"Nygren L, Baumgartner Wennerholm S, Klimkowska M, Christensson B, Kimby E, Sander B (2012) Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 119:4215\u20134223. https:\/\/doi.org\/10.1182\/blood-2011-12-400580","journal-title":"Blood"},{"key":"3022_CR29","doi-asserted-by":"publisher","first-page":"200313","DOI":"10.1016\/J.EHPC.2019.200313","volume":"17","author":"D Cantu","year":"2019","unstructured":"Cantu D, Alvarado Y, Murata-Collins J, Weisenburger DD (2019) Blastic transformation of mantle cell lymphoma with B-lymphoblastic features. Hum Pathol 17:200313. https:\/\/doi.org\/10.1016\/J.EHPC.2019.200313","journal-title":"Hum Pathol"},{"key":"3022_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.humpath.2018.06.027","volume":"81","author":"M Pizzi","year":"2018","unstructured":"Pizzi M, Brignola S, Righi S, Agostinelli C, Bertuzzi C, Pillon M, Semenzato G, Rugge M, Sabattini E (2018) Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall. Hum Pathol 81:131\u2013137. https:\/\/doi.org\/10.1016\/j.humpath.2018.06.027","journal-title":"Hum Pathol"},{"key":"3022_CR31","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1016\/j.ajpath.2016.07.027","volume":"186","author":"LM Slot","year":"2016","unstructured":"Slot LM, Hoogeboom R, Smit LA, Wormhoudt TAM, Biemond BJ, Oud MECM, Schilder-Tol EJM, Mulder AB, Jongejan A, van Kampen AHC, Kluin PM, Guikema JEJ, Bende RJ, van Noesel CJM (2016) B-lymphoblastic lymphomas evolving from follicular lymphomas co-express surrogate light chains and mutated gamma heavy chains. Am J Pathol 186:3273\u20133284. https:\/\/doi.org\/10.1016\/j.ajpath.2016.07.027","journal-title":"Am J Pathol"},{"key":"3022_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7497\/j.issn.2095-3941.2015.0007","volume":"12","author":"D-M Zhou","year":"2015","unstructured":"Zhou D-M, Chen G, Zheng X-W, Zhu WF, Chen BZ (2015) Clinicopathologic features of 112 cases with mantle cell lymphoma. Cancer Biol Med 12:46\u201352. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2015.0007","journal-title":"Cancer Biol Med"},{"key":"3022_CR33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJM198805263182106","volume":"318","author":"D de Jong","year":"1988","unstructured":"de Jong D, Voetdijk BM, Beverstock GC et al (1988) Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318:1373\u20131378. https:\/\/doi.org\/10.1056\/NEJM198805263182106","journal-title":"N Engl J Med"},{"key":"3022_CR34","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G, D\u00edaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Guti\u00e9rrez-Abril J, Vald\u00e9s-Mas R, L\u00f3pez C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Munta\u00f1ola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, L\u00f3pez-Guillermo A, K\u00fcppers R, Martin-Subero JI, Puente XS, Be\u00e0 S, Campo E (2020) Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes. Blood. 136:1419\u20131432. https:\/\/doi.org\/10.1182\/blood.2020005289","journal-title":"Blood."},{"key":"3022_CR35","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E (2012) Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 122:3416\u20133423. https:\/\/doi.org\/10.1172\/JCI61272","journal-title":"J Clin Invest"},{"key":"3022_CR36","doi-asserted-by":"publisher","unstructured":"Malarikova D, Berkova A, Obr A et al (2020) Concurrent TP53 and CDKN2A gene aberrations in newly diagnosed mantle cell lymphoma correlate with chemoresistance and call for innovative upfront therapy. Cancers 12. https:\/\/doi.org\/10.3390\/cancers12082120","DOI":"10.3390\/cancers12082120"},{"key":"3022_CR37","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","volume":"130","author":"CW Eskelund","year":"2017","unstructured":"Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, Montano-Almendras CP, Husby S, Freiburghaus C, Ek S, Pedersen A, Niemann C, R\u00e4ty R, Brown P, Geisler CH, Andersen MK, Guldberg P, Jerkeman M, Gr\u00f8nb\u00e6k K (2017) TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood 130:1903\u20131910. https:\/\/doi.org\/10.1182\/blood-2017-04-779736","journal-title":"Blood"},{"key":"3022_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.semcancer.2011.09.007","volume":"21","author":"C Royo","year":"2011","unstructured":"Royo C, Salaverria I, Hartmann EM, Rosenwald A, Campo E, Be\u00e0 S (2011) The complex landscape of genetic alterations in mantle cell lymphoma. Semin Cancer Biol 21:322\u2013334. https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.007","journal-title":"Semin Cancer Biol"},{"key":"3022_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1182\/blood-2015-02-628792","volume":"126","author":"M-H Delfau-Larue","year":"2015","unstructured":"Delfau-Larue M-H, Klapper W, Berger F, Jardin F, Briere J, Salles G, Casasnovas O, Feugier P, Haioun C, Ribrag V, Thieblemont C, Unterhalt M, Dreyling M, Macintyre E, Pott C, Hermine O, Hoster E, European Mantle Cell Lymphoma Network (2015) High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma. Blood 126:604\u2013611. https:\/\/doi.org\/10.1182\/blood-2015-02-628792","journal-title":"Blood"},{"key":"3022_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/gcc.22849","volume":"59","author":"L Streich","year":"2020","unstructured":"Streich L, Sukhanova M, Lu X, Chen YH, Venkataraman G, Mathews S, Zhang S, Kelemen K, Segal J, Gao J, Gordon L, Chen Q, Behdad A (2020) Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A\/B loss and TP53 mutations: a multi-institutional study. Genes Chromosom Cancer 59:484\u2013494. https:\/\/doi.org\/10.1002\/gcc.22849","journal-title":"Genes Chromosom Cancer"},{"key":"3022_CR41","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bjh.17023","volume":"191","author":"JM Rodrigues","year":"2020","unstructured":"Rodrigues JM, Hassan M, Freiburghaus C, Eskelund CW, Geisler C, R\u00e4ty R, Kolstad A, Sundstr\u00f6m C, Glimelius I, Gr\u00f8nb\u00e6k K, Kwiecinska A, Porwit A, Jerkeman M, Ek S (2020) p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma. Br J Haematol 191:796\u2013805. https:\/\/doi.org\/10.1111\/bjh.17023","journal-title":"Br J Haematol"},{"key":"3022_CR42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/blood-2017-04-737320","volume":"130","author":"JW Friedberg","year":"2017","unstructured":"Friedberg JW (2017) How I treat double-hit lymphoma. Blood 130:590\u2013596. https:\/\/doi.org\/10.1182\/blood-2017-04-737320","journal-title":"Blood"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03022-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T01:05:16Z","timestamp":1627002316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03022-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3022"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03022-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the recommendations of the ethics board of the Medical Faculty, University of Kiel, numbers D425\/03, D447\/10 and amendment from 09.03.2010 which includes that based on the historic nature of several cases a written informed consent on participation and publication could not be obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"See the \u2018Ethics approval\u2019 section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"See the \u2018Ethics approval\u2019 section.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NA","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}